EUVIMEDEUVIMED entdecken
Crossref

Targeted Covalent Nanodrugs Reinvigorate Antitumor Immunity and Kill Tumors via Improving Intratumoral Accumulation and Retention of Doxorubicin

Zhijia Zhu, Yanxue Shang, Chukai Lin, Dongchen Zhang, Lili Ai, Youshan Li, Weihong Tan iD, Yanlan Liu iD, Zilong Zhao iD

ACS Nano · 21.01.2025 · 19 (2) · 2315-2333

DOI: 10.1021/acsnano.4c12447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 06.01.2025. Verfasst von Zhijia Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engi…. Hauptthemen laut MEDLINE: Doxorubicin, Nanoparticles, Antibiotics, Antineoplastic, Antineoplastic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Specifically improving the intratumoral accumulation and retention and achieving the maximum therapeutic efficacy of small-molecule chemotherapeutics remains a considerable challenge. To address the issue, we here reported near-infrared (NIR) irradiation-activatable targeted covalent nanodrugs by installing diazirine-labeled transferrin receptor 1 (TfR1)-targeted aptamers on PEGylated phospholipid-coated upconversion nanoparticles followed by doxorubicin loading. Targeted covalent nanodrugs recognized and then were activated to covalently cross-link with TfR1 on cancer cells by 980 nm NIR irradiation. Systematic studies revealed that they achieved >6- and >5.5-fold higher intratumoral accumulations of doxorubicin than aptamer-based targeted nanodrugs at 6 and 120 h post intravenous injection, respectively. Based on high drug delivery efficacy, targeted covalent nanodrugs boosted doxorubicin-induced immunogenic cell death, activated antitumor immune responses and shrank the sizes of both primary and distant tumors, and displayed better therapeutic efficacy and less adverse effect than targeted nanodrugs and commercial Doxil in 4T1 syngeneic breast tumor model featuring an immunosuppressive microenvironment. By integrating the specificity of molecular recognition, the reactivity profile of diazirine and the accuracy of light manipulation with nanodrug supremacy, our targeted covalent nanodrugs could be expected as a longer-term and efficient strategy to improve anticancer therapeutic efficacy of chemotherapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinNanoparticlesAntibiotics, AntineoplasticAntineoplastic AgentsAnimalsMiceFemaleHumansMice, Inbred BALB CCell Line, TumorReceptors, TransferrinAptamers, NucleotideInfrared Rays

Stichwörter der Autor:innen

antitumor immunityaptamerimmunogenic cell deathnanomedicinetargeted covalent nanodrugs

Substanzen

DoxorubicinReceptors, TransferrinAntibiotics, AntineoplasticAntineoplastic AgentsAptamers, Nucleotide

Autor:innen und Institutionen

  • Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Aptamer Engineering Center of Hunan Province, Hunan Universit…
  • The Key Laboratory of Zhejiang Province for Aptamers and Theranostics, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.

ORCID-Profile: Weihong Tan, Yanlan Liu, Zilong Zhao

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhu, Z., Shang, Y., Lin, C., Zhang, D., Ai, L., Li, Y., Tan, W., Liu, Y., & Zhao, Z. (2025). Targeted Covalent Nanodrugs Reinvigorate Antitumor Immunity and Kill Tumors via Improving Intratumoral Accumulation and Retention of Doxorubicin. ACS Nano, 19(2), 2315-2333. https://doi.org/10.1021/acsnano.4c12447

Vancouver

Zhu Z, Shang Y, Lin C, Zhang D, Ai L, Li Y, et al. Targeted Covalent Nanodrugs Reinvigorate Antitumor Immunity and Kill Tumors via Improving Intratumoral Accumulation and Retention of Doxorubicin. ACS Nano. 2025;19(2):2315-2333. doi:10.1021/acsnano.4c12447

BibTeX
@article{Zhu2025,
  author = {Zhu, Zhijia and Shang, Yanxue and Lin, Chukai and Zhang, Dongchen and Ai, Lili and Li, Youshan and Tan, Weihong and Liu, Yanlan and Zhao, Zilong},
  title = {Targeted Covalent Nanodrugs Reinvigorate Antitumor Immunity and Kill Tumors via Improving Intratumoral Accumulation and Retention of Doxorubicin},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {2},
  pages = {2315--2333},
  doi = {10.1021/acsnano.4c12447}
}
Kostenlos starten →